{"slideshow_credits": null, "snippet": "Teva Pharmaceutical Industries of Israel named Jeremy Levin of Bristol-Myers Squibb as its next chief executive.", "abstract": "Teva Pharmaceutical Industries of Israel names Jeremy Levin of Bristol-Myers Squibb as chief executive and president, effective in May.", "section_name": "Business Day", "print_page": "2", "document_type": "article", "byline": {"person": [{"firstname": "Bloomberg", "role": "reported", "lastname": "NEWS", "rank": 1, "organization": ""}], "original": "By BLOOMBERG NEWS", "contributor": ""}, "web_url": "http://www.nytimes.com/2012/01/03/business/teva-names-a-new-chief-executive.html", "lead_paragraph": "Teva Pharmaceutical Industries of Israel named Jeremy Levin of Bristol-Myers Squibb as its next chief executive.", "headline": {"main": "Teva Names a New Chief Executive", "print_headline": "Teva Names a New Chief Executive", "content_kicker": "Business Briefing | Company News"}, "_id": "5404c82a38f0d8119d1575ad", "word_count": "128", "multimedia": [], "pub_date": "2012-01-03T00:00:00Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"value": "Teva Pharmaceutical Industries Ltd", "name": "organizations", "is_major": "Y", "rank": "1"}, {"value": "Appointments and Executive Changes", "name": "subject", "is_major": "N", "rank": "2"}], "blog": [], "subsection_name": null, "type_of_material": "Brief"}